Search Results - "Vega, Arantza"
-
1
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM
Published in Journal of allergy and clinical immunology (01-02-2014)“…Background Indolent systemic mastocytosis (ISM) without skin lesions (ISMs− ) shows a higher prevalence in males, lower serum baseline tryptase levels, and KIT…”
Get full text
Journal Article -
2
Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies
Published in Frontiers in allergy (14-01-2022)“…Rapid drug desensitization (RDD) allows first-line therapies in patients with immediate drug hypersensitivity reactions (DHR) to chemotherapeutic drugs (ChD)…”
Get full text
Journal Article -
3
Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-09-2013)“…Background A preferential association between systemic mastocytosis (SM) and hymenoptera allergy (HVA) has been observed. Patients with both diseases are at…”
Get full text
Journal Article -
4
Hymenoptera Allergy Diagnosis through Their Presence on Human Food
Published in Toxins (01-12-2023)“…Venom immunotherapy (VIT) protects up to 98% of treated Hymenoptera allergy patients from reactions with new stings. A correct diagnosis with the…”
Get full text
Journal Article -
5
Intradermal Phleum pratense allergoid immunotherapy. Double‐blind, randomized, placebo‐controlled trial
Published in Clinical and experimental allergy (01-12-2020)“…Background In allergology, the intradermal approach is generally used to establish an aetiological diagnosis, with limited experience in specific allergen…”
Get full text
Journal Article -
6
Importance of Component Resolved Diagnosis of Vespula/Polistes Allergic Patients
Published in Journal of allergy and clinical immunology (01-02-2013)Get full text
Journal Article -
7
Venom Immunotherapy in Patients with Clonal Mast CELL Disorders: Efficacy, Safety and Practical Considerations
Published in Journal of allergy and clinical immunology (01-02-2013)Get full text
Journal Article -
8
Clinical Practice Guide for Anaphylaxis in Latin America (Galaxia-Latam)
Published in Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) (01-08-2019)“…Anaphylaxis is a severe allergic reaction with a rapid onset and it is potentially life-threatening. Its clinical manifestations are varied; they may affect…”
Get full text
Journal Article -
9
Impact of climate change on insect–human interactions
Published in Current opinion in allergy and clinical immunology (01-10-2019)“…PURPOSE OF REVIEWTo update the influence of the global climate change on Hymenoptera venom allergy. RECENT FINDINGSClimate change facilitates biological…”
Get full text
Journal Article -
10
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatment
Published in Allergy (Copenhagen) (01-08-2023)“…Insect venom allergy is the most frequent cause of anaphylaxis in Europe and possibly worldwide. The majority of systemic allergic reactions after insect…”
Get full text
Journal Article -
11
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms
Published in Journal of allergy and clinical immunology (01-06-2010)“…Background Systemic mast cell activation disorders (MCADs) are characterized by severe and systemic mast cell (MC) mediators–related symptoms frequently…”
Get full text
Journal Article -
12
-
13
Venom Immunotherapy: an Updated Review
Published in Current allergy and asthma reports (01-07-2014)“…Venom immunotherapy (VIT) is the most effective form of specific immunotherapy to date. Hitherto, several relevant queries remain unanswered, namely optimal…”
Get full text
Journal Article -
14
Hypersensitivity Reactions to Cancer Chemotherapy: Practical Recommendations of ARADyAL for Diagnosis and Desensitization
Published in Journal of investigational allergology & clinical immunology (01-01-2021)“…Rapid drug desensitization has enabled first-line therapies in patients with drug hypersensitivity reactions to chemotherapeutic drugs including monoclonal…”
Get full text
Journal Article -
15
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
Published in Journal of allergy and clinical immunology (01-02-2008)“…Background Anaphylaxis after Hymenoptera sting has been described in patients with mastocytosis. Venom immunotherapy (VIT) is a safe and effective way to treat…”
Get full text
Journal Article -
16
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis
Published in Immunotherapy (01-05-2011)“…Systemic mastocytosis (SM) is typically suspected in patients with cutaneous mastocytosis (CM). In recent years, the presence of clonal mast cells (MCs) in a…”
Get more information
Journal Article -
17
Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
Published in Clinical and translational allergy (18-07-2014)Get full text
Journal Article -
18
Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: an Allergists’ Consensus
Published in Clinical and translational allergy (07-11-2014)“…Background Polysensitisation is common in patients with respiratory allergy in Spain. Selection of the best allergen immunotherapy (AIT) is difficult in…”
Get full text
Journal Article -
19
Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects
Published in The World Allergy Organization journal (16-11-2017)“…Allergen penetration through epithelium to the body is important for allergic sensitizations (cf.percutaneous sensitization to food allergens). Because…”
Get full text
Journal Article -
20